Hyderabad, India (CU)_ At Yashoda Hospitals based in Hyderabad, India, the Department of Cardiology, Cardiothoracic and Heart-Lung mechanical assist devices team successfully implanted the newest JARVIK post auricular (behind the ear) driveline to the 31-year-old young Ugandan patient. Mr. Okwara Joseph is a professional footballer. In April 2021, he suffered chest trouble while playing football in Uganda.

Following the chest pain, he was diagnosed with coronary artery disease and severe Left Ventricular dysfunction, and was admitted to hospital in Uganda on many occasions with complaints of dyspnea, swelling of both lower limbs, and abdominal distension. He was subsequently diagnosed with ischemic cardiomyopathy and traveled to India in November for advanced treatment. On December 13th, he was taken to Yashoda Hospitals for severe heart failure symptoms.

A multidisciplinary team of physicians from the Departments of Cardiology, Cardiothoracic Surgery, Heart and Lung mechanical assist device extensively reviewed the patient and decided that a left ventricular assist device would be the best destination therapy. Yashoda Hospitals provides the most modern treatment modality (JARVIK 2000 SERIES) with cutting edge facilities and the most advanced equipment. Mr. Okwara Joseph underwent successful surgery on 24th December 2021, received a new lease on life, and was discharged from Yashoda Hospitals in Hyderabad, India on 28th January 2022.

JARVIK 2000 series is a modern and cutting-edge LVAD device that is used as a destination treatment for patients with severe stage heart failure, providing them an array of hope with a fresh lease of life. Dr. Pavan Gorukanti, Director of Yashoda Hospitals, spoke about the advanced treatments at the hospital. He said, “Yashoda Hospitals, Hyderabad has one of the best cardiac, heart and lung transplantation teams in the world with matching infrastructure providing the best-in-class services, latest and best technologies and pioneers in performing the complex procedures.”

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here